{"id":61372,"date":"2025-06-04T19:05:17","date_gmt":"2025-06-04T17:05:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/eclinical-solutions-to-lead-industry-discussions-on-modernizing-clinical-trials-at-dia-2025-and-series-of-company-events-this-summer\/"},"modified":"2025-06-04T19:05:17","modified_gmt":"2025-06-04T17:05:17","slug":"eclinical-solutions-to-lead-industry-discussions-on-modernizing-clinical-trials-at-dia-2025-and-series-of-company-events-this-summer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/eclinical-solutions-to-lead-industry-discussions-on-modernizing-clinical-trials-at-dia-2025-and-series-of-company-events-this-summer\/","title":{"rendered":"eClinical Solutions to Lead Industry Discussions on Modernizing Clinical Trials at DIA 2025 and Series of Company Events This Summer"},"content":{"rendered":"
\n

\nGlobal eClinical Connect events kick off this week, leading up to annual ENGAGE conference in the fall, as company continues to build innovative avenues to empower life sciences leaders<\/i><\/p>\n

BOSTON–(BUSINESS WIRE)–eClinical Solutions LLC<\/a>, a global provider of digital clinical software and services, today announced its participation in several June events, including the DIA 2025<\/a> Global Annual Meeting, a leading life sciences event that brings together industry professionals to drive large-scale collaboration and transformation in the sector. With the company\u2019s commitment to supporting biopharma researchers in driving tomorrow\u2019s breakthroughs, eClinical is also hosting the eClinical Connect event series, including two events in Europe, creating additional global forums for industry experts to share insights and actionable strategies to tackle today\u2019s most pressing issues in the life sciences.<\/p>\n

<\/a>
<\/a><\/p>\n

\nDIA 2025 Global Annual Meeting<\/b><\/p>\n

\nFollowing years of industry and regulatory efforts to ensure inclusive and representative trials, including Diversity Action Plans, leaders are collaborating to make tangible progress on initiatives promoting clinical trial diversity<\/a>. To support these efforts, eClinical Solutions will host a panel at DIA (June 15-19 in Washington, DC) titled “Techquity in Digital Trials: Tech, Data, and Operationalizing Equity in Clinical Research<\/a>,” which will explore how biopharma can leverage data foundations and technological advancements – including artificial intelligence (AI) and machine learning (ML) – to improve access and representation in clinical trials.<\/p>\n

\neClinical Solutions\u2019 Katrina Rice, Chief Delivery Officer of Biometrics Services, will chair the panel and be joined by industry authorities including Patrick Gee, Patient Advocate, Founder and Chief Executive Hope Dealer at iAdvocate, Inc., Nicole Ward, Senior Product Manager, Business Insights and Technology at Bristol Myers Squibb, and Del Smith, CEO and Co-founder at Acclinate. The discussion will focus on critical areas where technology and analytics can help facilitate health equity advancement, outline concrete use cases where technology and data can support equitable clinical research, and detail non-technical success factors needed to wholly support data-driven technology. The conversation will take place June 18 between 1:45 pm – 2:45 pm ET.<\/p>\n

\neClinical Connect<\/b><\/p>\n

\nIn addition to its presence at this premier industry conference, the company will host three complimentary, global eClinical Connect events this month, which feature timely and informative panel discussions:<\/p>\n